What Is Antibody-Mediated Rejection in Histologic Diagnosis in Liver Recipients?.
10.4285/jkstn.2017.31.1.1
- Author:
Kyoung Bun LEE
1
Author Information
1. Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. kblee@snuh.org
- Publication Type:Review
- Keywords:
Graft rejection;
Liver transplantation;
Histology;
Complement 4d
- MeSH:
Collagen;
Diagnosis*;
Eosinophilia;
Eosinophils;
Fibrosis;
Graft Rejection;
Heart;
Hepatitis;
Humans;
Inflammation;
Isoantibodies;
Kidney;
Liver Transplantation;
Liver*;
Sensitivity and Specificity;
Tissue Donors;
Transplants
- From:The Journal of the Korean Society for Transplantation
2017;31(1):1-5
- CountryRepublic of Korea
- Language:English
-
Abstract:
Antibody-mediated rejection (AMR) is a rare event in liver transplantation compared to other solid organs such as the kidney and heart because of the different immunologic reactions in the liver and it ability to compensate for damage. Although it is not easy to define the histological features that help diagnosis because of its rarity, a few histologic features such as portal eosinophilia with eosinophilic endothelialitis have been reported as useful for diagnosis of acute AMR in presensitized patients. C4d staining is not a good indicator of AMR in liver grafts because of its low sensitivity and specificity. AMR is an emerging cause of chronic graft failure, especially in high risk patients having preformed or de novo donor specific alloantibodies (DSA). Some histologic parameters including interface hepatitis, lobular inflammation, portal collagenation, portal venopathy, and sinusoidal fibrosis, have been suggested as chronic AMR to predict graft fibrosis and survival in DSA positive patients. In conclusion, recent studies have resulted in the histological diagnostic criteria of AMR becoming more specific; however, confirmation of AMR still requires strong clinical evidence for alloantibodies.
